You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁克生物(300463.SZ):一季度淨利預降35%-40%
格隆匯 04-09 17:59

格隆匯4月9日丨邁克生物(300463.SZ)披露2020年第一季度業績預告,公司預計2020年1-3月實現歸屬於上市公司股東的淨利潤7105.33萬元-7697.44萬元,同比下降40%-35%。

由於國內新型冠狀病毒感染的肺炎疫情的爆發,全國上下全面抗擊疫情,各級醫療機構就診和體檢人數較上年同期大幅下降,對公司相關產品的銷售產生直接影響,公司2020年第一季度營業收入同比下滑,歸屬於上市公司股東的淨利潤較上年同期同比下降。

隨着國內疫情趨於穩定,公司業務有望穩步回升。與此同時,公司將密切關注全球疫情發展態勢並積極應對,為抗擊疫情提供有效檢測產品和防控服務。

報告期內,預計2020年第一季度非經常性損益對淨利潤的影響為-240萬元左右,主要系新冠疫情物資捐贈。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account